Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Author Correction: The Henna pigment Lawsone activates the Aryl Hydrocarbon Receptor and impacts skin homeostasis.
Lozza L, Moura-Alves P, Domaszewska T, Crespo CL, Streata I, Kreuchwig A, Puyskens A, Bechtle M, Klemm M, Zedler U, Ungureanu BS, Guhlich-Bornhof U, Koehler AB, Stäber M, Mollenkopf HJ, Hurwitz R, Furkert J, Krause G, Weiner J 3rd, Jacinto A, Mihai I, Leite-de-Moraes M, Siebenhaar F, Maurer M, Kaufmann SHE. Lozza L, et al. Among authors: koehler ab. Sci Rep. 2020 May 20;10(1):8640. doi: 10.1038/s41598-020-65510-2. Sci Rep. 2020. PMID: 32433586 Free PMC article.
The Henna pigment Lawsone activates the Aryl Hydrocarbon Receptor and impacts skin homeostasis.
Lozza L, Moura-Alves P, Domaszewska T, Lage Crespo C, Streata I, Kreuchwig A, Puyskens A, Bechtle M, Klemm M, Zedler U, Silviu Ungureanu B, Guhlich-Bornhof U, Koehler AB, Stäber M, Mollenkopf HJ, Hurwitz R, Furkert J, Krause G, Weiner J 3rd, Jacinto A, Mihai I, Leite-de-Moraes M, Siebenhaar F, Maurer M, Kaufmann SHE. Lozza L, et al. Among authors: koehler ab. Sci Rep. 2019 Jul 26;9(1):10878. doi: 10.1038/s41598-019-47350-x. Sci Rep. 2019. PMID: 31350436 Free PMC article.
cGAS facilitates sensing of extracellular cyclic dinucleotides to activate innate immunity.
Liu H, Moura-Alves P, Pei G, Mollenkopf HJ, Hurwitz R, Wu X, Wang F, Liu S, Ma M, Fei Y, Zhu C, Koehler AB, Oberbeck-Mueller D, Hahnke K, Klemm M, Guhlich-Bornhof U, Ge B, Tuukkanen A, Kolbe M, Dorhoi A, Kaufmann SH. Liu H, et al. Among authors: koehler ab. EMBO Rep. 2019 Apr;20(4):e46293. doi: 10.15252/embr.201846293. Epub 2019 Mar 14. EMBO Rep. 2019. PMID: 30872316 Free PMC article.
AhR sensing of bacterial pigments regulates antibacterial defence.
Moura-Alves P, Faé K, Houthuys E, Dorhoi A, Kreuchwig A, Furkert J, Barison N, Diehl A, Munder A, Constant P, Skrahina T, Guhlich-Bornhof U, Klemm M, Koehler AB, Bandermann S, Goosmann C, Mollenkopf HJ, Hurwitz R, Brinkmann V, Fillatreau S, Daffe M, Tümmler B, Kolbe M, Oschkinat H, Krause G, Kaufmann SH. Moura-Alves P, et al. Among authors: koehler ab. Nature. 2014 Aug 28;512(7515):387-92. doi: 10.1038/nature13684. Epub 2014 Aug 13. Nature. 2014. PMID: 25119038
Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.
Kosydar SR, Parikh SA, Lester SC, Rabe KG, Ding W, Burlile JF, Kenderian SS, Wang Y, Muchtar E, Koehler AB, Schwager SM, Slager SL, Kay NE, Call TG, Breen WG, Hampel PJ. Kosydar SR, et al. Among authors: koehler ab. Am J Hematol. 2023 Nov;98(11):E318-E321. doi: 10.1002/ajh.27060. Epub 2023 Aug 24. Am J Hematol. 2023. PMID: 37614209 No abstract available.
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study.
Huntington SF, Schuster SJ, Ding W, Koehler AB, Brander DM, Rosenthal AC, Leis JF, Tun HW, Moustafa MA, Iqbal M, He W, Kearney AS, McKinlay TP, Gui M, Mato AR. Huntington SF, et al. Among authors: koehler ab. Am J Hematol. 2023 May;98(5):739-749. doi: 10.1002/ajh.26888. Epub 2023 Mar 7. Am J Hematol. 2023. PMID: 36810799 Free article. Clinical Trial.
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.
Hampel PJ, Rabe KG, Call TG, Ding W, Leis JF, Chanan-Khan AA, Kenderian SS, Muchtar E, Wang Y, Ailawadhi S, Koehler AB, Parrondo R, Schwager SM, Sher T, Hanson CA, Shi M, Van Dyke DL, Braggio E, Slager SL, Kay NE, Parikh SA. Hampel PJ, et al. Among authors: koehler ab. Blood Cancer J. 2022 Sep 1;12(9):124. doi: 10.1038/s41408-022-00721-6. Blood Cancer J. 2022. PMID: 36050317 Free PMC article.
Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia.
Hampel PJ, Rabe KG, Call TG, Ding W, Leis JF, Kenderian SS, Muchtar E, Wang Y, Koehler AB, Parrondo R, Schwager SM, Shi M, Braggio E, Slager SL, Kay NE, Parikh SA. Hampel PJ, et al. Among authors: koehler ab. Br J Haematol. 2022 Oct;199(2):239-244. doi: 10.1111/bjh.18357. Epub 2022 Jul 16. Br J Haematol. 2022. PMID: 35841338
26 results